Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $809,622 - $1.18 Million
14,100 New
14,100 $1.12 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $262,755 - $337,500
4,500 New
4,500 $278,000
Q2 2022

Aug 15, 2022

SELL
$21.74 - $46.75 $15,217 - $32,725
-700 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$23.7 - $41.39 $16,590 - $28,973
700 New
700 $29,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.38B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.